Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
Status:
Terminated
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies glutamine in preventing peripheral neuropathy in
patients with multiple myeloma who are receiving bortezomib. Glutamine may help prevent
peripheral neuropathy in patients receiving chemotherapy